By Max Savage Levenson
CBD news and products keep coming at us all hot and heavy, Leafly Nation.
In the last 30 days, scientists found a common CBD claim didn’t hold up, but cannabidiol did help with opioid withdrawal.
CBD’s mainstreaming also continued with a major sports deal. Plus, we found some new gummies, capsules, and tinctures we like—even one from Travis frickin’ Barker.
Leafly rounds up everything from the last month that’s fit to post about America’s second favorite pot molecule (after THC). Get up to speed with this essential rundown below.
Clinical Trial: CBD Dosing Reduces Anxiety, Improves Cognitive Performance [NORML]
Cannabis, menopause, and the endocannabinoid system. “I’ve seen patients throughout most of the hormonal transitions. And I have seen cannabis be very, very helpful,” said Dr. Genester Wilson-King. [Project CBD]
Review: Data Suggests Role for CBD in Managing Opioid Withdrawal Symptoms. “Growing evidence suggests that CBD may have the potential to reduce anxiety, pain, and insomnia with also some signals for reducing craving, nausea, vomiting, muscle spasms, and blood pressure.” [NORML]
Major League Baseball became the first major sports league to ink a sponsorship deal with a CBD company last month. On October 12, Charlotte’s Web became “The Official CBD of Major League Baseball.” The partnership coincides with the launch of the CBD company’s Charlotte’s Web SPORT- Daily Edge tincture, a broad-spectrum product (meaning that the extract contains a range of cannabinoids from the hemp plant, but no THC).
“The CEO of edibles company Wana Brands is ponying up $3 million to further cannabis and psychedelic research at Johns Hopkins University (JHU).” [TheGrowthOp]
Legendary goth-metal band Type O Negative has jumped on the CBD train. #SureWhyNot.
Their signature Blackberry No. 1 tincture—a cute reference to their spooky scary 1993 single “Black No. 1”—dropped last week, in collaboration with Texas-based Whole Organix.
Read more on